Track Helus Pharma's total current liabilities ($18M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Helus Pharma (HELP) currently reports a total current liabilities of $18M as of June 2026. That compares with $15M in the prior-year period — up 20.5% year over year. Use the charts on this page to explore Helus Pharma's total current liabilities history and peer comparisons.
Helus Pharma's total current liabilities increased from $15M to $18M — a 20.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Helus Pharma reported $18M in total current liabilities as of June 2026. That compares with $15M in the prior-year period — up 20.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Helus Pharma, and consider following HELP for alerts when major investors trade the stock.
Helus Pharma is classified in the Healthcare sector. On total current liabilities, it currently shows $18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HELP with unrelated industries.